FAMHP unveils its strategic plan 2025-2027

date: 30/01/2025

The Federal Agency for Medicines and Health Products (FAMHP) is proud to present its new strategic plan for the years 2025-2027. 

This ambitious plan, devised in close cooperation with our employees and our different stakeholders, opens a new chapter for our agency and is also marked by the arrival of our new Chief Executive Officer, Hugues Malonne, at the end of 2023.

The strategic plan 2025-2027 is based on four main pillars.

  1. A well-performing organisation: we will promote excellence and operational efficiency in our tools, processes and structures to deliver quality service.
  2. Visibility of our commitments: we will strengthen our position as a reference authority in the medicines and health products sector through effective communication and trust-based relationships and partnerships.
  3. The FAMHP, a partner in the health care ecosystem of today and tomorrow: by supporting innovative technologies and thanks to its expertise, the FAMHP is recognised as a proactive and major player in implementing policies in the medicines and health products sector.
  4. An excellent working environment: we foster a culture of continuous learning, autonomy and well-being. Our employees have the skills and abilities needed to fulfil their responsibilities effectively and meet the evolving challenges of the sector.

Find out more about this strategic plan and follow our social media to keep informed of our progress.

Last updated on